Verstovsek, S., Talpaz, M., Wadleigh, M., Isidori, A., te Boekhorst, P., Savona, M. R., Bose, P., Pozdnyakova, O., Mesa, R., El-Galaly, T. C., O’Sullivan, J., Gamel, K., Higgins, B., Katakam, S., Todorov, B., Trunzer, K. and Harrison, C. N. (2024) “A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial”, Haematologica. Pavia, Italy, 109(6), pp. 1977-1983. doi: 10.3324/haematol.2023.284410.